VAN ECK ASSOCIATES CORP - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 66 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2019$66,000
+22.2%
19,760
+11.1%
0.00%
Q3 2019$54,000
+28.6%
17,783
+0.3%
0.00%
Q2 2019$42,000
-44.7%
17,724
-12.4%
0.00%
Q1 2019$76,000
+7.0%
20,223
+2.4%
0.00%
Q4 2018$71,000
+9.2%
19,752
+75.1%
0.00%
Q3 2018$65,000
+22.6%
11,278
+6.1%
0.00%
Q2 2018$53,000
+20.5%
10,632
+24.0%
0.00%
Q1 2018$44,000
-8.3%
8,575
+7.1%
0.00%
Q4 2017$48,000
-23.8%
8,003
-29.5%
0.00%
Q3 2017$63,000
+26.0%
11,351
+4.7%
0.00%
Q2 2017$50,000
-9.1%
10,844
-2.3%
0.00%
Q1 2017$55,000
-55.3%
11,1010.0%0.00%
-100.0%
Q4 2016$123,000
-10.2%
11,101
-25.2%
0.00%0.0%
Q3 2016$137,000
+45.7%
14,831
+0.4%
0.00%
Q2 2016$94,000
-5.1%
14,776
-2.8%
0.00%
-100.0%
Q1 2016$99,000
-19.5%
15,202
+0.6%
0.00%0.0%
Q4 2015$123,000
+29.5%
15,114
+17.2%
0.00%0.0%
Q3 2015$95,00012,9010.00%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q4 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 4,781,708$28,738,0004.90%
DSC Advisors, L.P. 1,187,604$7,138,0004.14%
Opaleye Management Inc. 960,000$5,769,0001.85%
DAFNA Capital Management LLC 352,741$2,120,0001.14%
Vivo Capital, LLC 855,000$5,139,0001.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 382,838$2,301,0000.81%
SENZAR ASSET MANAGEMENT, LLC 377,397$2,268,0000.58%
Sio Capital Management, LLC 131,200$789,0000.44%
Perceptive Advisors 1,117,324$6,715,0000.22%
Tekla Capital Management LLC 930,398$5,592,0000.22%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders